CLINICAL_TRIALS
trial_result
· 2018-04-02
Clinical Trial Update: 30 Day Rehospitalization Risk in Hemodialysis Patients [NA]
Summary
The trial evaluating 30-day rehospitalization risk in hemodialysis patients has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Northwell Health | Conditions: Re-hospitalization Hemodialysis | NA | Status: TERMINATED